Frontier Dispatch: Deep Tech Conversations
The conversation covers the development of novel neurotherapeutics by Xylo, the motivation and impact behind the work, Xylo's unfair advantage, Zoma Labs' continuous glucose monitoring, their unfair advantage, and Currus Biologics' cell therapy for solid tumors. Hosted by Elaine Stead.
4 Episoder
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Frontier Dispatch: Deep Tech Conversations sitt community!